🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to demonstrate that an investigational refrige...
Status
Completed
Location
Multiple Locations
Start Date
2002-09-26
Trial ID
NCT00092430
The purpose of this study is to determine the mumps virus strength at the e...
Status
Completed
Location
Multiple Locations
Start Date
1999-02
Trial ID
NCT00092391
This study will assess the safety and immunogenicity of ProQuad when admini...
Status
Completed
Location
Multiple Locations
Start Date
2000-06
Trial ID
NCT00984295
This study will test the safety, tolerability, and immunogenicity of VARIVA...
Status
Completed
Location
Multiple Locations
Start Date
2009-01
Trial ID
NCT00822237
This study will compare ProQuad™ and concomitant administration of M-M-R™ I...
Status
Terminated
Location
Multiple Locations
Start Date
2008-02
Trial ID
NCT00839917
A Study comparing three different doses of ProQuad to concomitant administr...
Status
Completed
Location
Multiple Locations
Start Date
1999-04
Trial ID
NCT00986232
Primary Objective: * To demonstrate that ProQuad® can be administered conc...
Status
Completed
Location
Multiple Locations
Start Date
2007-01-12
Trial ID
NCT00432042
Treatments Being Tested
This study will compare Measles, Mumps, Rubella, and Varicella Vaccine (V22...
Status
Completed
Location
Multiple Locations
Start Date
1998-03
Trial ID
NCT00975507
This study will compare three consistency lots of ProQuad to each other as ...
Status
Completed
Location
Multiple Locations
Start Date
2000-03
Trial ID
NCT00985153
The study was conducted to determine if ProQuad may be used in place of the...
Status
Completed
Location
Multiple Locations
Start Date
2000-08
Trial ID
NCT00985166